Quantius
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Toronto St, Toronto, Ontario, CanadaPhone Number
(416) 214-7588Website
www.quantius.caRevenue
$5.5 MillionIndustry
About Quantius
Is Quantius your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Quantius is spiking on competitors!
Product Launch: Get notified when Quantius launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Quantius had a recent Job posting/layoffs
Check if Quantius has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Quantius recently announced quarterly report
Quantius, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Quantius
Funding: Get notified immidiatlly once Quantius has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Quantius as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Quantius is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Quantius is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Quantius.
Quantius Tech Stack
A closer look at the technologies used by Quantius
Quantius News & Media
Acerus Secures Additional CDN $2M under the Quantius Loan Facility
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) announced today that it has received an additional $2 million under its secured term credit facility with Quantius Inc. (the “Quantius Facility”). This additional $2 million represented the second tranche of the $5 million Quantius Facility entered into late in 2017 and was conditional on Acerus achieving certain commercial milestones. These conditions included our U.S. Partner for NATESTO® reachiAcerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing Initiatives
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) today reported that it has entered into a senior secured term credit facility with Quantius Inc. for up to Cdn. $5 million. $3 million was available at closing, with the remaining $2 million becoming available upon satisfaction of certain future conditions, including 1) our U.S. Partner for NATESTO® achieving a set number of prescriptions per month, and 2) maintaining ESTRACE® sales at a set minimum level. The credit facilit
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Quantius
Quantius is currently under construction and has not yet released information about its products or services. The company is expected to provide updates in the near future. Details regarding its intended clients are also not available at this time. Interested parties are encouraged to check back for further announcements.... Read More